z-logo
Premium
Successful salvage of primary progressive Hodgkin lymphoma with the combination of post‐transplant brentuximab vedotin and radiotherapy: Combining novelty and tradition
Author(s) -
Belia Marina,
Chatzidimitriou Chrysovalantou,
Rondogianni Phivi,
Petsa Panayiota,
Efstathopoulou Maria,
Konstantinou Eliana,
Arapaki Maria,
Asimakopoulos John,
Plata Eleni,
Konstantopoulos Kostas,
Angelopoulou Maria K.,
Vassilakopoulos Theodoros P.
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2801
Subject(s) - brentuximab vedotin , medicine , hodgkin lymphoma , novelty , oncology , radiation therapy , lymphoma , psychology , social psychology

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom